Edition:
United Kingdom

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

4.83USD
13 Dec 2018
Change (% chg)

$0.08 (+1.68%)
Prev Close
$4.75
Open
$4.77
Day's High
$4.86
Day's Low
$4.66
Volume
18,320
Avg. Vol
46,639
52-wk High
$6.96
52-wk Low
$2.42

Latest Key Developments (Source: Significant Developments)

Adma Biologics Q3 Loss Per Share $0.33
Thursday, 8 Nov 2018 

ADMA Biologics Inc ::ADMA BIOLOGICS REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.33.Q3 EARNINGS PER SHARE VIEW $-0.31 -- THOMSON REUTERS I/B/E/S.Q3 REVENUE $4.2 MILLION VERSUS I/B/E/S VIEW $4.7 MILLION.  Full Article

ADMA Biologics Receives PDUFA Date For Bivigam Regulatory Submission
Thursday, 26 Jul 2018 

July 26 (Reuters) - ADMA Biologics Inc ::ADMA BIOLOGICS RECEIVES PDUFA DATE FOR BIVIGAM REGULATORY SUBMISSION.ADMA BIOLOGICS INC - ONCE PAS IS APPROVED, ADMA INTENDS TO RELAUNCH BIVIGAM IN U.S.ADMA BIOLOGICS INC - TARGET ACTION DATE FOR PAS IS OCTOBER 25, 2018 UNDER PRESCRIPTION DRUG USER FEE ACT.ADMA BIOLOGICS - ANTICIPATES RELAUNCHING BIVIGAM, UTILIZING 3 PRODUCED CONFORMANCE LOTS TO GENERATE ACCRETIVE REVENUE IN ADVANCE OF/DURING Q1 2019.  Full Article

Adma Biologics Says On July 19, Biotest Pharmaceuticals Corp And Co's Unit Entered Into Amendment No. 1 To Plasma Supply Agreement, Dated June 6, 2017
Tuesday, 24 Jul 2018 

July 24 (Reuters) - ADMA Biologics Inc ::ADMA BIOLOGICS - ON JULY 19, BIOTEST PHARMACEUTICALS CORP AND CO'S UNIT ENTERED INTO AMENDMENT NO. 1 TO PLASMA SUPPLY AGREEMENT, DATED JUNE 6, 2017.ADMA BIOLOGICS - AGREEMENT PROVIDES FOR THE SALE BY BPC TO ADMA BIOMANUFACTURING OF HYPERIMMUNE PLASMA CONTAINING ANTIBODIES TO THE HEPATITIS B VIRUS.  Full Article

ADMA Biologics Says Public Offering Of 8.37 Mln Common Shares Priced At $4.78 Per Share
Friday, 8 Jun 2018 

June 8 (Reuters) - ADMA Biologics Inc ::ADMA BIOLOGICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK.ADMA BIOLOGICS INC <<>> SAYS PUBLIC OFFERING OF 8.37 MLN COMMON SHARES PRICED AT $4.78/SHR.  Full Article

ADMA Biologics Files For Mixed Shelf Offering Of Up To $100 Mln
Friday, 18 May 2018 

May 18 (Reuters) - ADMA Biologics Inc ::ADMA BIOLOGICS FILES FOR MIXED SHELF OFFERING OF UP TO $100 MILLION - SEC FILING.  Full Article

Adma Biologics prices follow-on offering of 17.0 mln shares
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Adma Biologics Inc :Adma Biologics announces pricing of follow-on offering.Adma Biologics Inc - ‍pricing of offering of approximately 17.0 million shares of its common stock at price of $2.15 per share​.  Full Article

ADMA Biologics now sees offering‍​ of 13.6 mln shares of common stock - SEC filing
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - ADMA Biologics Inc ::Now sees offering‍​ of 13.6 million shares of its common stock, up from previous filing of 10.2 million shares - SEC filing.  Full Article

ADMA Biologics Q3 loss per share $0.59
Friday, 3 Nov 2017 

Nov 3 (Reuters) - ADMA Biologics Inc ::ADMA Biologics provides corporate update and reports third quarter 2017 financial results.Q3 loss per share $0.59.Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S.Q3 revenue rose 61 percent to $4.7 million.Q3 revenue view $6.5 million -- Thomson Reuters I/B/E/S.  Full Article

ADMA Biologics says ‍loss per share was $0.59 for fiscal quarter ended Sept 30​
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Adma Biologics Inc :ADMA Biologics Inc says ‍for fiscal quarter ended September 30, loss per share was $0.59 - SEC filing​.ADMA Biologics Inc - qtrly total revenues $4.7 million versus $2.9 million ‍​.  Full Article

Adma Biologics Inc files for offering of up to $28.75‍​ million of common stock
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - Adma Biologics Inc ::Adma Biologics Inc files for offering of up to $28.75‍​ million of common stock .  Full Article